These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28923104)

  • 61. Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
    Yang SC; Grimm EA; Parkinson DR; Carinhas J; Fry KD; Mendiguren-Rodriguez A; Licciardello J; Owen-Schaub LB; Hong WK; Roth JA
    Cancer Res; 1991 Jul; 51(14):3669-76. PubMed ID: 1648441
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development.
    Lavilla-Alonso S; Bauer MM; Abo-Ramadan U; Ristimäki A; Halavaara J; Desmond RA; Wang D; Escutenaire S; Ahtiainen L; Saksela K; Tatlisumak T; Hemminki A; Pesonen S
    Cancer Gene Ther; 2012 Feb; 19(2):126-34. PubMed ID: 22095385
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments.
    Shirakawa Y; Tazawa H; Tanabe S; Kanaya N; Noma K; Koujima T; Kashima H; Kato T; Kuroda S; Kikuchi S; Kagawa S; Katsui K; Kanazawa S; Urata Y; Fujiwara T
    Eur J Cancer; 2021 Aug; 153():98-108. PubMed ID: 34153720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.
    Francini N; Cochrane D; Illingworth S; Purdie L; Mantovani G; Fisher K; Seymour LW; Spain SG; Alexander C
    Bioconjug Chem; 2019 Apr; 30(4):1244-1257. PubMed ID: 30874432
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer.
    Otto F; Schmid P; Mackensen A; Wehr U; Seiz A; Braun M; Galanos C; Mertelsmann R; Engelhardt R
    Eur J Cancer; 1996 Sep; 32A(10):1712-8. PubMed ID: 8983279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
    Lê H; Deforges J; Cutolo P; Lamarque A; Hua G; Lindner V; Jain S; Balloul JM; Benkirane-Jessel N; Quéméneur E
    Front Immunol; 2024; 15():1379613. PubMed ID: 38698850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.
    van Putten EHP; Kleijn A; van Beusechem VW; Noske D; Lamers CHJ; de Goede AL; Idema S; Hoefnagel D; Kloezeman JJ; Fueyo J; Lang FF; Teunissen CE; Vernhout RM; Bakker C; Gerritsen W; Curiel DT; Vulto A; Lamfers MLM; Dirven CMF
    Clin Cancer Res; 2022 Apr; 28(8):1572-1585. PubMed ID: 35176144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation.
    Taverner WK; Jacobus EJ; Christianson J; Champion B; Paton AW; Paton JC; Su W; Cawood R; Seymour LW; Lei-Rossmann J
    Mol Ther Oncolytics; 2019 Dec; 15():117-130. PubMed ID: 31890865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus.
    Lorence RM; Roberts MS; O'Neil JD; Groene WS; Miller JA; Mueller SN; Bamat MK
    Curr Cancer Drug Targets; 2007 Mar; 7(2):157-67. PubMed ID: 17346107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.
    Dyer A; Di Y; Calderon H; Illingworth S; Kueberuwa G; Tedcastle A; Jakeman P; Chia SL; Brown A; Silva MA; Barlow D; Beadle J; Hermiston T; Ferguson DJ; Champion B; Fisher KD; Seymour LW
    Mol Ther Oncolytics; 2017 Mar; 4():18-30. PubMed ID: 28345021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.
    Pokrovska TD; Jacobus EJ; Puliyadi R; Prevo R; Frost S; Dyer A; Baugh R; Rodriguez-Berriguete G; Fisher K; Granata G; Herbert K; Taverner WK; Champion BR; Higgins GS; Seymour LW; Lei-Rossmann J
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endotoxin (Salmonella abortus equi) in cancer patients. Clinical and immunological findings.
    Engelhardt R; Otto F; Mackensen A; Mertelsmann R; Galanos C
    Prog Clin Biol Res; 1995; 392():253-61. PubMed ID: 8524930
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.
    Palmer CD; Rappaport AR; Davis MJ; Hart MG; Scallan CD; Hong SJ; Gitlin L; Kraemer LD; Kounlavouth S; Yang A; Smith L; Schenk D; Skoberne M; Taquechel K; Marrali M; Jaroslavsky JR; Nganje CN; Maloney E; Zhou R; Navarro-Gomez D; Greene AC; Grotenbreg G; Greer R; Blair W; Cao MD; Chan S; Bae K; Spira AI; Roychowdhury S; Carbone DP; Henick BS; Drake CG; Solomon BJ; Ahn DH; Mahipal A; Maron SB; Johnson B; Rousseau R; Yelensky R; Liao CY; Catenacci DVT; Allen A; Ferguson AR; Jooss K
    Nat Med; 2022 Aug; 28(8):1619-1629. PubMed ID: 35970920
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Toxicology and biodistribution of AdAPT-001, a replication-competent type 5 adenovirus with a trap for the immunosuppressive cytokine, TGF-beta.
    Larson C; Oronsky B; Abrouk NE; Oronsky A; Reid TR
    Am J Cancer Res; 2021; 11(10):5184-5189. PubMed ID: 34765319
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer.
    Skalicky A; Bennett B; Raimbourg J; Lonardi S; Correll J; Lugowska I; Dixon M; Sargalo N; Martin ML
    Front Pharmacol; 2024; 15():1310546. PubMed ID: 38601466
    [No Abstract]   [Full Text] [Related]  

  • 78. Commentary: Prehabilitation for increasing ventilatory efficiency before lung resection: Amazing concept, but we're not there yet!
    Ben Ali W; Liberman M; Perrault LP
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2513-2514. PubMed ID: 30954302
    [No Abstract]   [Full Text] [Related]  

  • 79. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
    Lang FF; Conrad C; Gomez-Manzano C; Yung WKA; Sawaya R; Weinberg JS; Prabhu SS; Rao G; Fuller GN; Aldape KD; Gumin J; Vence LM; Wistuba I; Rodriguez-Canales J; Villalobos PA; Dirven CMF; Tejada S; Valle RD; Alonso MM; Ewald B; Peterkin JJ; Tufaro F; Fueyo J
    J Clin Oncol; 2018 May; 36(14):1419-1427. PubMed ID: 29432077
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis.
    Lauer UM; Schell M; Beil J; Berchtold S; Koppenhöfer U; Glatzle J; Königsrainer A; Möhle R; Nann D; Fend F; Pfannenberg C; Bitzer M; Malek NP
    Clin Cancer Res; 2018 Sep; 24(18):4388-4398. PubMed ID: 29773661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.